326 related articles for article (PubMed ID: 17145940)
1. Modification of the structure of peptidoglycan is a strategy to avoid detection by nucleotide-binding oligomerization domain protein 1.
Wolfert MA; Roychowdhury A; Boons GJ
Infect Immun; 2007 Feb; 75(2):706-13. PubMed ID: 17145940
[TBL] [Abstract][Full Text] [Related]
2. The Dual NOD1/NOD2 Agonism of Muropeptides Containing a Meso-Diaminopimelic Acid Residue.
Dagil YA; Arbatsky NP; Alkhazova BI; L'vov VL; Mazurov DV; Pashenkov MV
PLoS One; 2016; 11(8):e0160784. PubMed ID: 27513337
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and proinflammatory properties of muramyl tripeptides containing lysine and diaminopimelic acid moieties.
Roychowdhury A; Wolfert MA; Boons GJ
Chembiochem; 2005 Nov; 6(11):2088-97. PubMed ID: 16222728
[TBL] [Abstract][Full Text] [Related]
4. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
[TBL] [Abstract][Full Text] [Related]
5. NOD1 and NOD2 stimulation triggers innate immune responses of human periodontal ligament cells.
Jeon DI; Park SR; Ahn MY; Ahn SG; Park JH; Yoon JH
Int J Mol Med; 2012 Apr; 29(4):699-703. PubMed ID: 22218461
[TBL] [Abstract][Full Text] [Related]
6. The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists.
Netea MG; Ferwerda G; de Jong DJ; Werts C; Boneca IG; Jéhanno M; Van Der Meer JW; Mengin-Lecreulx D; Sansonetti PJ; Philpott DJ; Dharancy S; Girardin SE
J Biol Chem; 2005 Oct; 280(43):35859-67. PubMed ID: 16115863
[TBL] [Abstract][Full Text] [Related]
7. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid.
Chamaillard M; Hashimoto M; Horie Y; Masumoto J; Qiu S; Saab L; Ogura Y; Kawasaki A; Fukase K; Kusumoto S; Valvano MA; Foster SJ; Mak TW; Nuñez G; Inohara N
Nat Immunol; 2003 Jul; 4(7):702-7. PubMed ID: 12796777
[TBL] [Abstract][Full Text] [Related]
8. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of conformationally constrained γ-D-glutamyl-meso-diaminopimelic acid derivatives as ligands of nucleotide-binding oligomerization domain protein 1 (Nod1).
Jakopin Ž; Gobec M; Kodela J; Hazdovac T; Mlinarič-Raščan I; Sollner Dolenc M
Eur J Med Chem; 2013 Nov; 69():232-43. PubMed ID: 24044936
[TBL] [Abstract][Full Text] [Related]
10. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists.
Fritz JH; Girardin SE; Fitting C; Werts C; Mengin-Lecreulx D; Caroff M; Cavaillon JM; Philpott DJ; Adib-Conquy M
Eur J Immunol; 2005 Aug; 35(8):2459-70. PubMed ID: 16021602
[TBL] [Abstract][Full Text] [Related]
11. The role of nucleotide-binding oligomerization domain 1 during cytokine production by macrophages in response to Mycobacterium tuberculosis infection.
Lee JY; Hwang EH; Kim DJ; Oh SM; Lee KB; Shin SJ; Park JH
Immunobiology; 2016 Jan; 221(1):70-5. PubMed ID: 26255090
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages.
Takahashi Y; Isuzugawa K; Murase Y; Imai M; Yamamoto S; Iizuka M; Akira S; Bahr GM; Momotani E; Hori M; Ozaki H; Imakawa K
J Vet Med Sci; 2006 May; 68(5):471-8. PubMed ID: 16757890
[TBL] [Abstract][Full Text] [Related]
13. NOD1 activation induces innate immune responses and insulin resistance in human adipocytes.
Zhou YJ; Zhou H; Li Y; Song YL
Diabetes Metab; 2012 Dec; 38(6):538-43. PubMed ID: 23182460
[TBL] [Abstract][Full Text] [Related]
14. LipL21 lipoprotein binding to peptidoglycan enables Leptospira interrogans to escape NOD1 and NOD2 recognition.
Ratet G; Santecchia I; Fanton d'Andon M; Vernel-Pauillac F; Wheeler R; Lenormand P; Fischer F; Lechat P; Haake DA; Picardeau M; Boneca IG; Werts C
PLoS Pathog; 2017 Dec; 13(12):e1006725. PubMed ID: 29211798
[TBL] [Abstract][Full Text] [Related]
15. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
[TBL] [Abstract][Full Text] [Related]
16. NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases.
Pashenkov MV; Dagil YA; Pinegin BV
Int Immunopharmacol; 2018 Jan; 54():385-400. PubMed ID: 29207344
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and validation of click-modified NOD1/2 agonists.
Bharadwaj R; Anonick MV; Jaiswal S; Mashayekh S; Brown A; Wodzanowski KA; Okuda K; Silverman N; Grimes CL
Innate Immun; 2023 Nov; 29(8):186-200. PubMed ID: 37828863
[TBL] [Abstract][Full Text] [Related]
18. The effects of NOD activation on adipocyte differentiation.
S Purohit J; Hu P; Burke SJ; Collier JJ; Chen J; Zhao L
Obesity (Silver Spring); 2013 Apr; 21(4):737-47. PubMed ID: 23712977
[TBL] [Abstract][Full Text] [Related]
19. Centaurin beta1 down-regulates nucleotide-binding oligomerization domains 1- and 2-dependent NF-kappaB activation.
Yamamoto-Furusho JK; Barnich N; Xavier R; Hisamatsu T; Podolsky DK
J Biol Chem; 2006 Nov; 281(47):36060-70. PubMed ID: 17005562
[TBL] [Abstract][Full Text] [Related]
20. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ
Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
